Pre-radiotherapy identification of individual genomic profile to avoid, by resort to customized radiosensitizers, the risk of radioresistance development in patients with localized prostate cancer: author reply
- PMID: 25363875
- PMCID: PMC4277390
- DOI: 10.1259/bjr.20140701
Pre-radiotherapy identification of individual genomic profile to avoid, by resort to customized radiosensitizers, the risk of radioresistance development in patients with localized prostate cancer: author reply
Comment on
-
An arranged marriage for precision medicine: hypoxia and genomic assays in localized prostate cancer radiotherapy.Br J Radiol. 2014 Mar;87(1035):20130753. doi: 10.1259/bjr.20130753. Epub 2014 Feb 3. Br J Radiol. 2014. PMID: 24588670 Free PMC article. Review.
-
Pre-radiotherapy identification of individual genomic profile to avoid, by resort to customized radiosensitizers, the risk of radioresistance development in patients with localized prostate cancer.Br J Radiol. 2015 Jan;88(1045):20140630. doi: 10.1259/bjr.20140630. Br J Radiol. 2015. PMID: 25363844 Free PMC article. No abstract available.
References
-
- Roach MM, Hanks GG, Thames HH, Schellhammer PP, Shipley WU, Sokol GHG, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006; 65: 965–74. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
